Matches in Nanopublications for { ?s ?p "[SCN1A mutation may be a clinically-useful genetic marker in order to distinguish GEFS+ patients from those with classic idiopathic generalised epilepsy, even if they present an atypical clinical picture.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP682474.RAReb7gNwrWsxxc3tthV50_ynRmt5Uv399zKHKptki0Tc130_assertion description "[SCN1A mutation may be a clinically-useful genetic marker in order to distinguish GEFS+ patients from those with classic idiopathic generalised epilepsy, even if they present an atypical clinical picture.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682474.RAReb7gNwrWsxxc3tthV50_ynRmt5Uv399zKHKptki0Tc130_provenance.
- NP1183901.RAys8pm9VN0rk8XCNWmoE4S5cftmjCjwE3EPzLwY8tX9M130_assertion description "[SCN1A mutation may be a clinically-useful genetic marker in order to distinguish GEFS+ patients from those with classic idiopathic generalised epilepsy, even if they present an atypical clinical picture.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1183901.RAys8pm9VN0rk8XCNWmoE4S5cftmjCjwE3EPzLwY8tX9M130_provenance.
- assertion description "[SCN1A mutation may be a clinically-useful genetic marker in order to distinguish GEFS+ patients from those with classic idiopathic generalised epilepsy, even if they present an atypical clinical picture.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.